Sanjeev Krishna
#150,097
Most Influential Person Now
Researcher
Sanjeev Krishna's AcademicInfluence.com Rankings
Sanjeev Krishnacomputer-science Degrees
Computer Science
#10467
World Rank
#10994
Historical Rank
Machine Learning
#4787
World Rank
#4841
Historical Rank
Artificial Intelligence
#5154
World Rank
#5221
Historical Rank
Database
#7460
World Rank
#7733
Historical Rank
Download Badge
Computer Science
Sanjeev Krishna's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Sanjeev Krishna Influential?
(Suggest an Edit or Addition)According to Wikipedia, Sanjeev Krishna, , is a British physician and parasitologist whose research focuses on affordable diagnosis and treatment of diseases such as COVID-19, malaria, Ebola, African trypanosomiasis, leishmaniasis, and colorectal cancer. Krishna is Professor of Medicine and Molecular Parasitology at St George's, University of London and St George's Hospital.
Sanjeev Krishna's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Artemisinins target the SERCA of Plasmodium falciparum (2003) (997)
- Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number (2004) (772)
- Aquaporin‐4 facilitates reabsorption of excess fluid in vasogenic brain edema (2004) (712)
- The trypanosomiases (2003) (524)
- Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. (2006) (397)
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe. (2016) (389)
- Aquaporin-4 expression is increased in oedematous human brain tumours (2002) (365)
- Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. (2008) (358)
- Pharmacokinetics of Quinine, Chloroquine and Amodiaquine (1996) (311)
- Artemisinins: their growing importance in medicine (2008) (309)
- Molecular mechanisms of brain tumor edema (2004) (273)
- Increased aquaporin 1 water channel expression inhuman brain tumours (2002) (272)
- Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum (2006) (259)
- Artemisinins: mechanisms of action and potential for resistance. (2004) (240)
- A single amino acid residue can determine the sensitivity of SERCAs to artemisinins (2005) (228)
- Severe falciparum malaria in Gabonese children: clinical and laboratory features (2005) (208)
- Genome variation and evolution of the malaria parasite Plasmodium falciparum (2007) (202)
- Severe malaria - a case of fatal Plasmodium knowlesi infection with post-mortem findings: a case report (2010) (190)
- Antimalarial combinations (2004) (176)
- The role of pfmdr1 in Plasmodium falciparum tolerance to artemether‐lumefantrine in Africa (2007) (167)
- Aquaporin water channels and brain edema. (2002) (164)
- Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. (2006) (160)
- Intraerythrocytic Plasmodium falciparum Expresses a High Affinity Facilitative Hexose Transporter* (1999) (148)
- A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer☆☆☆ (2014) (147)
- A novel and accurate diagnostic test for human African trypanosomiasis (2004) (147)
- Mycobacterium tuberculosis Expresses a Novel Ph-Dependent Divalent Cation Transporter Belonging to the Nramp Family (1999) (144)
- Validation of the hexose transporter of Plasmodium falciparum as a novel drug target (2003) (142)
- Artemisinins Inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense In Vitro Growth (2007) (130)
- Occludin expression in microvessels of neoplastic and non‐neoplastic human brain (2001) (129)
- Artemisinins: activities and actions. (2004) (120)
- Artemisinins (2005) (120)
- Metal ion homeostasis and intracellular parasitism (1998) (114)
- The Fe2+‐Mediated Decomposition, PfATP6 Binding, and Antimalarial Activities of Artemisone and Other Artemisinins: The Unlikelihood of C‐Centered Radicals as Bioactive Intermediates (2007) (111)
- Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance (2006) (110)
- Expression and Functional Characterization of a Plasmodium falciparum Ca2+-ATPase (PfATP4) Belonging to a Subclass Unique to Apicomplexan Organisms* (2001) (103)
- Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV (2017) (95)
- Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes. (2000) (94)
- Human African trypanosomiasis (2002) (94)
- Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network. (2006) (92)
- Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance (2006) (91)
- Bioavailability and Preliminary Clinical Efficacy of Intrarectal Artesunate in Ghanaian Children with Moderate Malaria (2001) (89)
- HIV-1 suppression during acute scrub-typhus infection (2000) (86)
- Life cycle studies of the hexose transporter of Plasmodium species and genetic validation of their essentiality (2010) (82)
- Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study. (2014) (80)
- Waking up to sleeping sickness. (2003) (78)
- Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. (2005) (76)
- Multiple Splice Variants Encode a Novel Adenylyl Cyclase of Possible Plastid Origin Expressed in the Sexual Stage of the Malaria Parasite Plasmodium falciparum* (2003) (75)
- Artemisinins and the biological basis for the PfATP6/SERCA hypothesis. (2010) (73)
- Host genetic factors determining COVID-19 susceptibility and severity (2021) (72)
- Intramuscular Bioavailability and Clinical Efficacy of Artesunate in Gabonese Children with Severe Malaria (2002) (72)
- Antimalarial multi-drug resistance in Asia: mechanisms and assessment. (2005) (71)
- Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy. (2013) (70)
- Antischistosomal activity of artemisinin derivatives in vivo and in patients. (2016) (69)
- Investigations into the Role of the Plasmodium falciparum SERCA (PfATP6) L263E Mutation in Artemisinin Action and Resistance (2010) (69)
- Evaluation of three rapid diagnostic tests for the detection of human infections with Plasmodium knowlesi (2014) (69)
- Water transport becomes uncoupled from K+ siphoning in brain contusion, bacterial meningitis, and brain tumours: immunohistochemical case review (2003) (68)
- Mechanistic Investigation of the Specific Anticancer Property of Artemisinin and Its Combination with Aminolevulinic Acid for Enhanced Anticolorectal Cancer Activity (2017) (68)
- Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. (2005) (67)
- Metal ion transport and regulation in Mycobacterium tuberculosis. (2004) (67)
- Population Pharmacokinetics of Artesunate and Dihydroartemisinin following Intra-Rectal Dosing of Artesunate in Malaria Patients (2006) (66)
- History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon (2007) (65)
- Acute respiratory distress syndrome in Plasmodium vivax malaria: case report and review of the literature. (2007) (65)
- Assessment of Volume Depletion in Children with Malaria (2004) (64)
- Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization☆ (2017) (63)
- A prospective comparison of malaria with other severe diseases in African children: prognosis and optimization of management. (2003) (63)
- Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite’s food vacuole and alter drug sensitivities (2015) (62)
- Purified E255L Mutant SERCA1a and Purified PfATP6 Are Sensitive to SERCA-type Inhibitors but Insensitive to Artemisinins* (2010) (61)
- Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic (2020) (61)
- Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test (2005) (60)
- Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey (2011) (59)
- Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand. (2007) (59)
- Mechanism of Antimalarial Action of the Synthetic Trioxolane RBX11160 (OZ277) (2006) (59)
- A Temporizing Solution to "Artemisinin Resistance". (2019) (58)
- Laboratory markers of disease severity in Plasmodium knowlesi infection: a case control study (2012) (56)
- Population Kinetics, Efficacy, and Safety of Dichloroacetate for Lactic Acidosis Due to Severe Malaria in Children (2003) (54)
- Prognostic value of circulating pigmented cells in African children with malaria. (2009) (54)
- Plasmodium knowlesi Genome Sequences from Clinical Isolates Reveal Extensive Genomic Dimorphism (2015) (54)
- Disease Progression in Plasmodium knowlesi Malaria Is Linked to Variation in Invasion Gene Family Members (2014) (53)
- Retaking sleeping sickness control in Angola (2004) (52)
- Proteomic analysis of the Plasmodium male gamete reveals the key role for glycolysis in flagellar motility (2014) (52)
- Cytoadherence and virulence - the case of Plasmodium knowlesi malaria (2012) (51)
- Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial (2017) (51)
- Glutathione transport: a new role for PfCRT in chloroquine resistance. (2013) (51)
- The Molecular Basis of Folate Salvage in Plasmodium falciparum (2011) (49)
- The prognostic value of measures of acid/base balance in pediatric falciparum malaria, compared with other clinical and laboratory parameters. (2005) (48)
- Cerebrospinal Fluid Neopterin as Marker of the Meningo-Encephalitic Stage of Trypanosoma brucei gambiense Sleeping Sickness (2012) (48)
- Short-Course Artesunate Treatment of Uncomplicated Plasmodium falciparum Malaria in Gabon (2003) (48)
- New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients (2013) (47)
- Malaria: Drugs, Disease and Post-genomic Biology (2005) (47)
- In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents (2011) (47)
- Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? (2015) (46)
- Susceptibility of human Plasmodium knowlesi infections to anti-malarials (2013) (46)
- Short-term economic impact of the Zika virus outbreak. (2016) (46)
- Inhibition of hexose transport and abrogation of pH homeostasis in the intraerythrocytic malaria parasite by an O‐3‐hexose derivative (2004) (45)
- Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial (2016) (45)
- A vacuolar iron-transporter homologue acts as a detoxifier in Plasmodium (2016) (45)
- Use of a Selective Inhibitor To Define the Chemotherapeutic Potential of the Plasmodial Hexose Transporter in Different Stages of the Parasite's Life Cycle (2011) (44)
- Population Pharmacokinetics of Intramuscular Quinine in Children with Severe Malaria (2001) (43)
- Differences in presentation of severe malaria in urban and rural Gabon. (2007) (43)
- Hexose transport in asexual stages of Plasmodium falciparum and kinetoplastidae. (2000) (42)
- Anti-Inflammatory Cytokines Predominate in Acute Human Plasmodium knowlesi Infections (2011) (41)
- Expression of thrombospondin-related anonymous protein in Plasmodium falciparum sporozoites (1992) (41)
- Dynamics of IgG seroconversion and pathophysiology of COVID-19 infections (2020) (41)
- Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family. (2002) (40)
- Pumped up: reflections on PfATP6 as the target for artemisinins. (2014) (40)
- Delayed haemolysis after artesunate treatment of severe malaria - review of the literature and perspective. (2015) (40)
- Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections (2012) (39)
- A simplified intravenous artesunate regimen for severe malaria. (2012) (39)
- pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies (2017) (39)
- Proteomic fingerprinting for the diagnosis of human African trypanosomiasis. (2005) (38)
- Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa (2011) (38)
- Repurposing Antimalarials to Tackle the COVID-19 Pandemic (2020) (38)
- Case reports: pernicious complications of benign tertian malaria. (2003) (38)
- A single amino acid residue can determine the sensitivity of SERCAs to artemisinins (2012) (37)
- The Plasmodium berghei Ca2+/H+ Exchanger, PbCAX, Is Essential for Tolerance to Environmental Ca2+ during Sexual Development (2013) (36)
- Exploiting the therapeutic potential of Plasmodium falciparum solute transporters. (2010) (36)
- Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature (2017) (35)
- Expression in yeast links field polymorphisms in PfATP6 to in vitro artemisinin resistance and identifies new inhibitor classes. (2013) (35)
- Science, medicine, and the future : malaria (1997) (35)
- Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis (2017) (34)
- Signalling in malaria parasites. The MALSIG consortium. (2009) (33)
- Transport processes in Plasmodium falciparum-infected erythrocytes: potential as new drug targets. (2002) (32)
- Prognostic indicators in adults hospitalized with falciparum malaria in Western Thailand (2013) (32)
- The Nramp orthologue of Cryptococcus neoformans is a pH-dependent transporter of manganese, iron, cobalt and nickel. (2005) (32)
- Neopterin Is a Cerebrospinal Fluid Marker for Treatment Outcome Evaluation in Patients Affected by Trypanosoma brucei gambiense Sleeping Sickness (2013) (30)
- Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro. (2007) (29)
- Comparison of effects of green tea catechins on apicomplexan hexose transporters and mammalian orthologues (2009) (28)
- New antimalarial targets: the example of glucose transport. (2008) (28)
- The wisdom of crowds and the repurposing of artesunate as an anticancer drug (2015) (28)
- The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. (2015) (27)
- Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing (2020) (27)
- IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection (2020) (27)
- CIPROFLOXACIN AND MALARIA (1988) (26)
- The current landscape of nucleic acid tests for filovirus detection (2018) (24)
- Evidence for Regulation of Hemoglobin Metabolism and Intracellular Ionic Flux by the Plasmodium falciparum Chloroquine Resistance Transporter (2018) (24)
- Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans (2018) (24)
- Studies with the Plasmodium falciparum hexokinase reveal that PfHT limits the rate of glucose entry into glycolysis (2013) (23)
- Antimalarial Activity of a Synthetic Endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum Isolates from Gabon (2006) (23)
- Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria (2017) (23)
- Effect of artemisinins and amino alcohol partner antimalarials on mammalian sarcoendoplasmic reticulum calcium adenosine triphosphatase activity. (2008) (22)
- Interaction of O-(undec-10-en)-yl-D-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT). (2007) (21)
- The hexose transporter of Plasmodium falciparum is a worthy drug target. (2004) (21)
- Molecular assays for antimalarial drug resistance surveillance: A target product profile (2018) (20)
- Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration (2020) (20)
- Transport proteins of Plasmodium falciparum: defining the limits of metabolism. (2001) (19)
- Why is the Plasmodium falciparum hexose transporter a promising new drug target? (2003) (18)
- Longitudinal Monitoring of Lactate in Hospitalized and Ambulatory COVID-19 Patients (2021) (18)
- Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against (2019) (18)
- The aquaporin‐4 water channel and brain tumour oedema (2002) (18)
- Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor. (2004) (17)
- Adjunctive management of malaria (2012) (17)
- Proteomic approaches in the search for biomarkers of liver fibrosis. (2010) (17)
- Methylene Homologues of Artemisone: An Unexpected Structure–Activity Relationship and a Possible Implication for the Design of C10‐Substituted Artemisinins (2016) (17)
- Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis (2021) (17)
- Comprar Treatment And Prevention Of Malaria: Antimalarial Drug Chemistry, Action And Use | Henry M. Staines | 9783034604796 | Springer (2012) (17)
- Nitric oxide generation in children with malaria and the NOS2G-954C promoter polymorphism. (2010) (17)
- Characterization of P-type ATPase 3 in Plasmodium falciparum. (2001) (16)
- Severe malaria in children leads to a significant impairment of transitory otoacoustic emissions - a prospective multicenter cohort study (2015) (16)
- Self-sampling of capillary blood for SARS-CoV-2 serology (2021) (16)
- Calcium as an intracellular messenger in eukaryotic microbes (1991) (16)
- Plasmodium berghei-infection induces volume-regulated anion channel-like activity in human hepatoma cells (2009) (15)
- Artemisone Uptake in Plasmodium falciparum-Infected Erythrocytes (2010) (14)
- Identification, expression and characterisation of a Babesia bovis hexose transporter (2008) (13)
- PLANT GROWTH PROMOTING RHIZOBACTERIA : AN EFFECTIVE TOOL TO REMEDIATE RESIDUAL ORGA- NOPHOSPHATE PESTICIDE METHYL PARATHION, WIDELY USED IN INDIAN AGRICULTURE (2015) (13)
- Mutational Analysis of the Hexose Transporter of Plasmodium falciparum and Development of a Three-dimensional Model* (2002) (13)
- Milestones in Drug Therapy (2006) (12)
- Plasmodium knowlesi: the Fifth Human Malarial Parasite (2010) (12)
- Artesunate versus quinine for severe falciparum malaria (2006) (12)
- Ebola: missed opportunities for Europe-Africa research. (2015) (11)
- Calcium metabolism in malaria-infected erythrocytes. (1990) (11)
- Expression of parasite transporters in Xenopus oocytes. (1999) (11)
- The effect of blood transfusion on outcomes among African children admitted to hospital with Plasmodium falciparum malaria: a prospective, multicentre observational study. (2020) (11)
- Estimation of Relevant Variables on High-Dimensional Biological Patterns Using Iterated Weighted Kernel Functions (2008) (10)
- Probing structure/affinity relationships for the Plasmodium falciparum hexose transporter with glucose derivatives. (2006) (10)
- Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection (2021) (10)
- Synthesis, hydrolysis studies and pharmacodynamic profile of novel colon-specific mutual prodrug of Aceclofenac with amino acids (2009) (9)
- Enhancement of Mycobacterium tuberculosis-Induced Tumor Necrosis Factor Alpha Production from Primary Human Monocytes by an Activated T-Cell Membrane-Mediated Mechanism (2001) (9)
- Short report: evaluation of a simple and inexpensive photometric device for the measurement of hemoglobin. (2004) (8)
- Identifi cation of diagnostic markers for tuberculosis by proteomic fi ngerprinting of serum (2006) (8)
- Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination (2020) (8)
- Rapid Diagnostic Algorithms as a Screening Tool for Tuberculosis: An Assessor Blinded Cross-Sectional Study (2012) (8)
- Suboptimal dosing triggers artemisinin partner drug resistance. (2019) (8)
- A genetic predisposition for Cytokine Storm in life-threatening COVID-19 infection (2020) (8)
- Antimalarial cocktail—tropical flavours of the month (2002) (8)
- Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination (2020) (7)
- Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment (2021) (7)
- Molecular approaches to malaria: glycolysis in asexual-stage parasites. (2005) (6)
- Answer to the comment of Hai Lu et al. regarding “Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report and review of the literature. Arch Toxicol (2016)” (2017) (6)
- Adaptation of in vitro cytoadherence assay to Plasmodium knowlesi field isolates (2010) (6)
- Assessment of traits for grain yield under drought in finger millet (2021) (5)
- Blood volume and red cell mass in children with moderate and severe malaria measured by chromium-53 dilution and gas chromatography/mass spectrometric analysis. (2009) (5)
- Artemisinin resistance needs to be defined rigorously to be understood: response to Dondorp and Ringwald. (2013) (5)
- Artemisinin Resistance and the Blame Game. (2016) (5)
- Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites (2014) (5)
- An efficient and novel technology for the extraction of parasite genomic DNA from whole blood or culture (2019) (5)
- The aquaporin‐1 water channel protein is abnormally expressed in oedematous human brain tumours (2002) (5)
- Drought adaptation: Approaches for crop improvement (2021) (4)
- Ophthalmoplegia and Slurred Speech in an Intravenous Drug User (2006) (4)
- Non-randomised Ebola trials--lessons for optimal outbreak research. (2016) (4)
- Drug Development Papers in PLoS Medicine: How We Try to Spot a Winner (2006) (4)
- Accuracy of the Mologic COVID-19 rapid antigen test: a prospective multi-centre analytical and clinical evaluation (2021) (4)
- Insights from compassionate use of tocilizumab for COVID‐19 to inform appropriate design of randomised controlled trials (2020) (4)
- Recent developments in the management of malaria (1999) (3)
- The QuantuMDx Q-POC SARS-CoV-2 RT-PCR assay for rapid detection of COVID-19 at point-of-care: preliminary evaluation of a novel technology (2021) (3)
- Non-Antifolate Antibiotics: Clindamycin, Doxycycline, Azithromycin and Fosmidomycin (2011) (3)
- Trypanosomiasis: African and American (2005) (2)
- Fluid therapy for severe malaria. (2022) (2)
- Transmembrane solute transport in the apicomplexan parasite Plasmodium. (2017) (2)
- Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia (2021) (2)
- in combination with other chemotherapeutic agents (2011) (2)
- How has mass drug administration with dihydroartemisinin-piperaquine impacted molecular markers of drug resistance? A systematic review (2022) (2)
- Homology model of the PfATP6 (2004) (2)
- Scaled testing for COVID-19 needs community involvement (2021) (2)
- Time-to-death is a potential confounder in observational studies of blood transfusion in severe malaria - Authors' reply. (2021) (2)
- More depth of field not wider focus needed (2011) (2)
- Assessment of cochlear damage after pneumococcal meningitis using otoacoustic emissions. (1997) (2)
- Investigating the Role of PGPM in Assisting Plant Growth Under Stress Caused by Organophosphate Pesticide-Phorate (2015) (2)
- EVALUATION OF ANTIMYCOTIC ACTIVITY OF Eucaly- ptus globulus, Datura stramonium AND Tagetes patula AGAINST THREE ECONOMICALLY IMPORTANT PLANT PATHOGENS (2015) (2)
- A call to caution when hydroxychloroquine is given to elderly patients with COVID-19 (2021) (1)
- Susceptibility of human Plasmodium knowlesi infections to anti-malarials (2013) (1)
- Proteomic analysis of the Plasmodium male gamete reveals the key role for glycolysis in flagellar motility (2014) (1)
- A Temporizing Solution to "Artemisinin Resistance". Reply. (2019) (1)
- Evaluation of three rapid diagnostic tests for the detection of human infections with Plasmodium knowlesi (2014) (1)
- 7 New approaches for old diseases: what to do about malaria? (2018) (1)
- Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections (2012) (1)
- Selective Inhibition of Plasmodium falciparum ATPase 6 by Artemisinins and Identification of New Classes of Inhibitors after Expression in Yeast (2022) (1)
- Rapid versus standard antibiotic susceptibility testing for treating bloodstream infections (2018) (1)
- Factors influencing antimicrobial prescription attitudes in bloodstream infections: susceptibility results and beyond. An exploratory survey. (2021) (1)
- Author Correction: Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination (2020) (1)
- Laboratory markers of disease severity in Plasmodium knowlesi infection: a case control study (2012) (1)
- Self-sampling of capillary blood for serological testing of SARS-CoV-2 by COVID-19 IgG ELISA (2020) (1)
- Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs (2022) (1)
- Cytoadherence and virulence - the case of Plasmodium knowlesi malaria (2012) (1)
- P‐Type ATPases in Tetrahymena (1997) (1)
- 97 – African Trypanosomiasis (2013) (1)
- Erratum to: Severe malaria in children leads to a significant impairment of transitory otoacoustic emissions - a prospective multicenter cohort study (2016) (1)
- Artesunate may attenuate the effects of Cytokine Release Syndrome (CRS) in Covid-19 Disease by targeting Interleukin-6 and associated inflammatory response pathways (2020) (1)
- Artesunate versus quinine for severe falciparum malaria [letter] (2006) (0)
- Protozoal Tropical Infections Trypanosomiasis: African and American What's New ? (0)
- Leukocytoclastic vasculitis following DPT vaccination (2015) (0)
- CORRIGENDUM: Genome variation and evolution of the malaria parasite Plasmodium falciparum (2007) (0)
- Reply to Ursing et al. (2006) (0)
- African Trypanosomiasis (2020) (0)
- Repurposing Antimalarials to Tackle the COVID-19 Pandemic (2021) (0)
- Artemisone accumulation in Plasmodium falciparum-infected human red blood cells. (2008) (0)
- SARS-CoV-2 Vaccine Immunogenicity in Patients with Gastrointestinal Cancer Receiving Systemic Anti-Cancer Therapy (2022) (0)
- Science and innovation in malaria diagnostics (2014) (0)
- Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria (2017) (0)
- Schizontocidal antimalarials: a reply (1990) (0)
- Response to Tocilizumab in Severe COVID-19 (2020) (0)
- Arsenic trioxide resistance in acute promyelocytic leukemia: More to it than PML mutations (2020) (0)
- The Nramp Homologue Encoded by Mycobacterium Tuberculosis is a Ph-Dependent Divalent Cation Transporter (1999) (0)
- Combining Arsenic Trioxide and Mitocans Selectively Disrupts Cellular Energetics in Acute Myeloid Leukemia (2021) (0)
- ONE-YEAR SAFETY OF THE RVSV∆G-ZEBOV-GP VACCINE IN ADOLESCENTS AND CHILDREN IN LAMBARENE, GABON (2017) (0)
- Erratum: Genome variation and evolution of the malaria parasite Plasmodium falciparum (Nature Genetics (2007) 39, (120-125)) (2007) (0)
- Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature (2016) (0)
- Evidence for Regulation of Hemoglobin Metabolism and Intracellular Ionic Flux by the Plasmodium falciparum Chloroquine Resistance Transporter (2018) (0)
- Widening the options for recurrent malaria (2018) (0)
- Entomological survey of the Himalayas. XII. Second annotated check-list of insects from the North-West Himalayas (1955) (0)
- Antimalarial treatment in infants (2022) (0)
- Models of malaria Elizabeth A Casman Hadi Dowlatabadi (2003) (0)
- Clinical Infectious Diseases: A Practical Approach edited by R.K. Root, F. Waldvogel, L. Corey and W.E. Stamm (1999) (0)
- Fluid therapy in sepsis? Pathogen-specific perspectives (2022) (0)
- Contributors (2021) (0)
- Assessment of traits for grain yield under drought in finger millet (2021) (0)
- Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against (2019) (0)
- Title : In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents Authors : (2011) (0)
- Perspective The N EW ENGL A N D JOU R NA L of M EDICI N E (2019) (0)
- List of Contributors (2020) (0)
- Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs (2022) (0)
- SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests (2022) (0)
- POS1195 ASSESSING ANTIBODY STATUS FOR SARS-CoV-2 IN PEOPLE WITH CORONAVIRUS INFECTION: A TIME COURSE STUDY IN PEOPLE WITH AUTOIMMUNE CONDITIONS (2021) (0)
- MODELED STRUCTURE OF THE PLASMODIUM FALCIPARUM HEXOSE TRANSPORTER PFHT1 (2002) (0)
- Development and Validation of an In Silico Decision Tool To Guide Optimization of Intravenous Artesunate Dosing Regimens for Severe Falciparum Malaria Patients (2021) (0)
- SAFETY OF RVSV EBOLA VACCINE, AFTER 6 MONTHS FOLLOW-UP, IN ADULTS: A PHASE 1 TRIAL CONDUCTED IN LAMBARÉNÉ, GABON (2017) (0)
- Vitamin D status of apparently healthy school going Indian children (2016) (0)
- Answer to the comment of Hai Lu et al. regarding “Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report and review of the literature. Arch Toxicol (2016)” (2017) (0)
- Randomized, controlled trial of treatments for second-stage sleeping sickness. (2007) (0)
- P057 What is the course of SARS-CoV-2 infection in people with autoimmune conditions on immunomodulators in comparison to people without autoimmune disease? (2021) (0)
- Selective inhibition of PfATP6 by artemisinins and identification of new classes of inhibitors after expression in yeast (2021) (0)
- Cerebral malaria complicated by acute liver failure (2000) (0)
- How has mass drug administration with dihydroartemisinin-piperaquine impacted molecular markers of drug resistance? A systematic review (2022) (0)
- 604 DIAGNOSIS OF SIGNIFICANT HCV LIVER FIBROSIS WITH SERUM PROTEOMIC PROFILING IN SUBJECTS WITH OPTIMAL LIVER BIOPSIES (2009) (0)
- Corrigendum: Genome variation and evolution of the malaria parasite Plasmodium falciparum (2007) (0)
- Mechanisms of Disease (1996) (0)
- Science and innovation in malaria diagnostics (2014) (0)
- WHO develops artesunate for emergency treatment of malaria (1999) (0)
- MicroReview Metal ion homeostasis and intracellular parasitism (1998) (0)
- Population dynamics and drug resistance mutations in Plasmodium falciparum on the Bijagós Archipelago, Guinea-Bissau. (2023) (0)
- Authors' Reply (2005) (0)
This paper list is powered by the following services:
Other Resources About Sanjeev Krishna
What Schools Are Affiliated With Sanjeev Krishna?
Sanjeev Krishna is affiliated with the following schools:
